期刊文献+

印度药物警戒系统概述 被引量:2

Overview of Pharmacovigilance Systems in India
下载PDF
导出
摘要 印度是世界上第4大药品市场,近年来印度不断借鉴西方先进的监管经验,改善其药品监管环境,药物警戒系统也逐渐受到印度政府的重视。本文从机构设置及职责、不良反应报告体系等方面对印度药物警戒法规进行简要介绍,提出建立药物警戒体系的重要性及相关措施。 India is the world's fourth largest pharmaceutical market, and it has been continuing to learn advanced supervisory experience from western countries in recent years to improve its drug regulatory environment, thus pharm- acovigilance system is gradually catching Indian government's attention. In this paper, institutions and its responsibilities, adverse reactions reporting system and other aspects of pharmacovigilance laws and regulations in India are briefly introduced, propose the importance of the establishment of pharmacovigilance system and some relevant measures.
作者 卢玉美
出处 《中国药物警戒》 2012年第7期413-417,共5页 Chinese Journal of Pharmacovigilance
关键词 药物警戒 印度 不良反应报告 pharmacovigilance India adverse reaction reports
  • 相关文献

参考文献10

  • 1BMI India pharmceutical and healthcare report 2011 [EB/OL].[2011- 06-01].http://store.businessmonitor.com/pharma/india_pharmace- utica.Is _and_ healthcare_report.
  • 2Deepa Arora.Pharmacovigilance obligations of the pharmaceutical companies in India [J]. Indian Journal of Pharmacology, 2008, 40 (2) .Supplement. 13-16.
  • 3The importance of pharmacovigilance: safety monitoring of medic- inaJ products[M]. Geneva: World Health Organization,2002,7.
  • 4Ashish Kumar Srivastava, GarimaGupta, Dr.S.K.Mishra, et al. Pharmacovigilance: A Global and Indian perspective[J]. Journal of Pharmacy Research, 2010,3(5): 1034-1048.
  • 5P Biswas, AK. Setting standards for proactive pharmacovigilance in India:the way ahead[J].Indian Journal of Pharmacology, 2007, 39:124,-128.
  • 6CDSCO.Pharmacovigilance Programme of India (PvPI) for Assur- ing Drug Safety [EB/OL].[2010-7-14]. http://cdsco.nic.in/pharm- acovigilance.htm.
  • 7India's Central Drugs Standard Control Organization (CDSCO) [EB/ OL].http://www.pacificbridgemedical.com/countries/india/cdsco.
  • 8PvPI.SUSPECTED ADVERSE DRUG REACTION REPORTING FORM [EB/OL].[2010-7-14].hup://cdscoxtic.in/pharmacovigilanceJatm.
  • 9PvPI.STANDARD OPERATING PROCEDURE-Causality assess- ment of ADR reports[M].National Coordinating Center,2011.
  • 10PvPI.STANDARD OPERATING PROCEDURE-Quality assur- ance of ADR reports [M].National Coordinating Center,2011.

同被引文献20

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部